don’t you think reon’s questions about substance, details, a plan, are relevant? If you don’t like it you can leave isn’t a very sophisticated position
- Forums
- ASX - By Stock
- NOX
- Ann: Noxopharm Announces Novel mRNA Vaccine Enhancer
Ann: Noxopharm Announces Novel mRNA Vaccine Enhancer, page-7
Featured News
Add NOX (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.8¢ |
Change
-0.013(10.4%) |
Mkt cap ! $33.60M |
Open | High | Low | Value | Volume |
11.0¢ | 11.5¢ | 10.8¢ | $21.50K | 195.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 120885 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.5¢ | 39408 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 120885 | 0.105 |
5 | 143641 | 0.100 |
1 | 53000 | 0.096 |
1 | 20000 | 0.095 |
1 | 11000 | 0.088 |
Price($) | Vol. | No. |
---|---|---|
0.115 | 39408 | 1 |
0.120 | 48477 | 2 |
0.125 | 66800 | 1 |
0.130 | 162463 | 5 |
0.135 | 30000 | 1 |
Last trade - 13.54pm 13/11/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online